Actavis, Inc. et al v. King Drug Company of Florence, Inc. et al
| Actavis, Inc., Actavis Holdco U.S., Inc., Par Pharmaceutical, Inc. and Paddock Laboratories, Inc. |
| King Drug Company of Florence, Inc., AmerisourceBergen Corp., Amerisourcebergen Drug Corp., BellCo Drug Co., H.D. Smith, LLC, Cardinal Health Inc., The harvad Drug Group, L.L.C., McKesson Corporation, J M Smith Corporation doing business as Smith Drug Company, Burlington Drug Company, Inc., The North Carolina Mutual Wholesale Drug Company, Dakota Drug Inc., Value Dug Company and FWK Holdings, LLC. |
| 1:2024mi00001 |
| January 10, 2024 |
| US District Court for the Northern District of Georgia |
| J P Boulee |
| Linda T Walker |
| Other Statutory Actions |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 12, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 8
ORDER GRANTING #4 Motion to Transfer Case. Accordingly, this civil action and Movants' Motion to Quash is hereby TRANSFERRED to the Eastern District of Pennsylvania. Signed by Judge J. P. Boulee on 1/12/2024. (nmb)
|
| Case transferred to District of USDC Eastern District of Pennsylvania. Original file, copy of transfer order and docket sheet sent. (nmb) |
| Miscellaneous Case Terminated. (nmb) |
| New MI Action Number in USDC EDPA 2:24-mc-0006 (aar) |
| Filing 7 Letter from Clerk re: LR 83.1 Pro Hac Vice requirements sent to Julia K. York. Clerk to follow-up by 1/22/2024. (djs) |
| Filing 6 Letter from Clerk re: LR 83.1 Pro Hac Vice requirements sent to Ryan Travers. Clerk to follow-up by 1/22/2024. (djs) |
| Filing 5 Letter from Clerk re: LR 83.1 Pro Hac Vice requirements sent to Sarah Kirkpatrick. Clerk to follow-up by 1/22/2024. (djs) |
| Filing 4 CONSENT MOTION TO TRANSFER VENUE by Actavis Holdco U.S., Inc., Actavis, Inc., Paddock Laboratories, Inc., Par Pharmaceutical, Inc.. (Attachments: #1 Proposed Order)(jkb) |
| Filing 3 Certificate of Interested Persons and Corporate Disclosure Statement by Actavis Holdco U.S., Inc. identifying Corporate Parent Teva Pharmaceuticals USA, Inc., Corporate Parent Teva Pharmaceuticals Industries Ltd., Corporate Parent Teva Ltd. for Actavis Holdco U.S., Inc. (jkb) |
| Filing 2 Certificate of Interested Persons and Corporate Disclosure Statement by Actavis, Inc. identifying Corporate Parent AbbVie Inc., Other Affiliate Allergan Finance LLC, Other Affiliate Watson Pharmaceuticals, Inc. for Actavis, Inc. (jkb) |
| Filing 1 MOTION to Quash Deposition Subpoenas, MOTION for Protective Order by Actavis Holdco U.S., Inc., Actavis, Inc., Paddock Laboratories, Inc., Par Pharmaceutical, Inc. (Attachments: #1 Memorandum of law in Support, #2 Declaration of Julia K. York, #3 Declaration of Sarah F. Kirkpatrick, #4 Exhibit B, #5 Exhibit B2, #6 Exhibit C, #7 Exhibit F, #8 Exhibit H, #9 Civil Cover Sheet)(jkb) |
| Filing Fee Paid: $ 52.00, receipt number AGANDC-13148721 (jkb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
